| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.67 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |